Drugs / lignoacaine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05165875 | Jun 2022 → Feb 2024 | de Quervain disease | National University Hospital, Singapore | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lignoacaine | “For the steroid injection group, a 1ml injection of a mixture of 0.5ml triamcinolone acetonide (50mg/5ml) and 0.5ml 1% lignoacaine is given intra-thecally into the first...” NCT05165875 ↗ |
| Route | Other | “is given intra-thecally into the first extensor compartment” NCT05165875 ↗ |